Technology area: Biotechnology & Pharmaceuticals
20 pending office actions • 20 art units • 20 examiners • 0 of 20 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
University of Tennessee Research Foundation has 24 pending office actions in Biotechnology & Pharmaceuticals. The actions involve 24 distinct examiners and 23 distinct art units, showing extensive dispersion across both examiner assignments and technical groups. This profile requires strong centralized docket control without assuming uniform examination practice.
TRAN, MICHAEL THANH is the busiest examiner, with 1 pending matter. No listed examiner provides a concentration point for portfolio-wide treatment, so counsel should organize work around recurring substantive issues while preparing responses for the individual art-unit and examiner contexts.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (15%) |
| §103 only | 5 (25%) |
| §102 only | 2 (10%) |
| Double-patenting only | 1 (5%) |
| Double-patenting + other | 1 (5%) |
| Multi-statute (no §101) | 8 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, MICHAEL THANH | 1 | 95.8% | +0.5% |
| ZHONG, WAYNESHAOBIN | 1 | 72.3% | +21.4% |
| SHTERENGARTS, SAMANTHA L | 1 | 79.5% | +8.0% |
| AGUDELO, PAOLA | 1 | 76.9% | +17.1% |
| JIANG, HAIMEI | 1 | 52.3% | +31.7% |
| GROOMS, TIFFANY NICOLE | 1 | 57.8% | +46.3% |
| ANBACHT, BRIT ELIZA | 1 | 73.6% | +20.7% |
| KINGDON, CATHY | 1 | 80.3% | +2.6% |
| MCKOY, QUINCY ANDRE | 1 | 68.4% | +39.8% |
| FERNANDES, PATRICK M | 1 | 59.9% | +31.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18973648 | CURRENT-CONTROLLED ANALOG MEMORY CIRCUITS BUILT FROM NON-VOLATILE MEMORY ELEMENTS | TRAN, MICHAEL THANH | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18385490 | SYSTEMS AND METHODS FOR PREDICTING GASTROINTESTINAL IMPAIRMENT | FERNANDES, PATRICK M | 4d overdue |
| 18194374 | METHOD FOR TREATING OBESITY AND/OR HYPERTENSION | MILLER, DALE R | 56d |
| 18124110 | METHODS AND COMPOSITIONS FOR INHIBITING ICE RECRYSTALLIZATION | VAN BUREN, LAUREN K | 76d |
| 18367112 | METHOD OF COMPUTER NUMERICAL CONTROL (CNC) MACHINING AND HYBRID MANUFACTURING | COLLINS, GARY | 77d |
| 18965202 | DISCOVERY OF SOYBEAN CYST NEMATODE RESISTANCE GENES BASED ON EPIGENETIC ANALYSIS | ZHONG, WAYNESHAOBIN | — |
| 18709175 | COMBINED TARGETING OF STAT3 AND ULKI TO TREAT GLIOBLASTOMA | GROOMS, TIFFANY NICOLE | — |
| 18695866 | FILTER MEDIA WITH BIODEGRADABLE FIBERS | ANBACHT, BRIT ELIZA | — |
| 18694018 | RESISTANCE GENES AGAINST ROOT KNOT-NEMATODES IN TOMATO | KINGDON, CATHY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18793307 | Method of Retrofitting Building Exteriors With Insulation And Cladding Construction | AGUDELO, PAOLA | 22d overdue |
| 18385490 | SYSTEMS AND METHODS FOR PREDICTING GASTROINTESTINAL IMPAIRMENT | FERNANDES, PATRICK M | 4d overdue |
| 18965202 | DISCOVERY OF SOYBEAN CYST NEMATODE RESISTANCE GENES BASED ON EPIGENETIC ANALYSIS | ZHONG, WAYNESHAOBIN | — |
| 18675826 | HARDWARE ENCODERS AND COMMUNICATION SYSTEMS FOR SPIKING NEURAL NETWORKS | JIANG, HAIMEI | — |
| 18709175 | COMBINED TARGETING OF STAT3 AND ULKI TO TREAT GLIOBLASTOMA | GROOMS, TIFFANY NICOLE | — |
| 18695866 | FILTER MEDIA WITH BIODEGRADABLE FIBERS | ANBACHT, BRIT ELIZA | — |
| 18612647 | BROMODOMAIN INHIBITORS FOR CANCER THERAPY | MCKOY, QUINCY ANDRE | — |
| Art Unit | Apps |
|---|---|
| 2827 | 1 |
| 1662 | 1 |
| 1623 | 1 |
| 3633 | 1 |
| 2142 | 1 |
| 1637 | 1 |
| 1776 | 1 |
| 1663 | 1 |
| 1626 | 1 |
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18973648 | CURRENT-CONTROLLED ANALOG MEMORY CIRCUITS BUILT FROM NON-VOLATILE MEMORY ELEMENTS | TRAN, MICHAEL THANH | 2827 | §102 | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18965202 | DISCOVERY OF SOYBEAN CYST NEMATODE RESISTANCE GENES BASED ON EPIGENETIC ANALYSIS | ZHONG, WAYNESHAOBIN | 1662 | §101§102DP | Non-Final OA | — | Pending | Dec 02, 2024 |
| 18885325 | COMPOUNDS FOR TREATMENT OF CANCER | SHTERENGARTS, SAMANTHA L | 1623 | DP | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18793307 | Method of Retrofitting Building Exteriors With Insulation And Cladding Construction | AGUDELO, PAOLA | 3633 | §103 | Final Rejection | 22d overdue | Pending | Aug 02, 2024 |
| 18675826 | HARDWARE ENCODERS AND COMMUNICATION SYSTEMS FOR SPIKING NEURAL NETWORKS | JIANG, HAIMEI | 2142 | §102Other | Non-Final OA | — | Pending | May 28, 2024 |
| 18709175 | COMBINED TARGETING OF STAT3 AND ULKI TO TREAT GLIOBLASTOMA | GROOMS, TIFFANY NICOLE | 1637 | §102§103§112 | Non-Final OA | — | Pending | May 10, 2024 |
| 18695866 | FILTER MEDIA WITH BIODEGRADABLE FIBERS | ANBACHT, BRIT ELIZA | 1776 | §102§103§112 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18694018 | RESISTANCE GENES AGAINST ROOT KNOT-NEMATODES IN TOMATO | KINGDON, CATHY | 1663 | §102§103§112 | Final Rejection | — | Pending | Mar 21, 2024 |
| 18612647 | BROMODOMAIN INHIBITORS FOR CANCER THERAPY | MCKOY, QUINCY ANDRE | 1626 | §102§112DP | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18385490 | SYSTEMS AND METHODS FOR PREDICTING GASTROINTESTINAL IMPAIRMENT | FERNANDES, PATRICK M | 3791 | §101§112DP | Final Rejection | 4d overdue | Pending | Oct 31, 2023 |
| 18489682 | W/O/W MICROEMULSIONS FOR OCULAR ADMINISTRATION | VANHORN, ABIGAIL LOUISE | 1636 | §101§103§112DP | Non-Final OA | — | Pending | Oct 18, 2023 |
| 18367112 | METHOD OF COMPUTER NUMERICAL CONTROL (CNC) MACHINING AND HYBRID MANUFACTURING | COLLINS, GARY | 2115 | §102§103 | Non-Final OA | 77d | Pending | Sep 12, 2023 |
| 18243215 | SELECTIVE CARBON BINDING ON CARBON QUANTUM DOTS | DAVIS, SHENG HAN | 1732 | §103 | Final Rejection | 4d overdue | Pending | Sep 07, 2023 |
| 18039949 | METHOD FOR DIAGNOSING AMYLOID DISEASES | KIM, KAITLYN EUNJI | 3797 | §103§112 | Final Rejection | — | Pending | Jun 01, 2023 |
| 18197849 | MUSCLE-DRIVEN ENDOPROSTHESIS SYSTEMS AND METHODS FOR USING SAME | COCHRAN, KARI LEE | 3774 | §103 | Final Rejection | 35d | Pending | May 16, 2023 |
| 18194374 | METHOD FOR TREATING OBESITY AND/OR HYPERTENSION | MILLER, DALE R | 1693 | §103§112 | Final Rejection | 56d | Pending | Mar 31, 2023 |
| 18124110 | METHODS AND COMPOSITIONS FOR INHIBITING ICE RECRYSTALLIZATION | VAN BUREN, LAUREN K | 1638 | §102§103 | Final Rejection | 76d | Pending | Mar 21, 2023 |
| 18120191 | PROGRAMMED CELLS FOR TARGETED ARTICULAR CARTILAGE AND BONE REGENERATION | BUTTICE, AUDREY L | 1644 | §102§103§112 | Non-Final OA | — | Pending | Mar 10, 2023 |
| 18109021 | CORONAVIRUS TREATMENT COMPOSITION AND METHOD | CREWS, JARET JAMES | 1691 | §103 | Final Rejection | 147d overdue | Pending | Feb 13, 2023 |
| 17717899 | ELECTRODES COMPRISING LIQUID/GAS DIFFUSION LAYERS AND SYSTEMS AND METHODS FOR MAKING AND USING THE SAME | CONTRERAS, CIEL P | 1794 | §103 | Final Rejection | 30d overdue | Pending | Apr 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Tennessee Research Foundation has 20 pending office actions as of October 2026, spread across 20 art units and 20 examiners.
Michael Thanh Tran has the most, with 1 of University of Tennessee Research Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
